{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:32:22Z","timestamp":1790875942168,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T00:00:00Z","timestamp":1582070400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T00:00:00Z","timestamp":1582070400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s11239-020-02061-3","type":"journal-article","created":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T10:02:33Z","timestamp":1582106553000},"page":"533-539","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Increasing use of anticoagulants in Germany and its impact on hospitalization rates for genitourinary bleeding"],"prefix":"10.1007","volume":"49","author":[{"given":"Olga","family":"von Beckerath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander Matthias","family":"Paulitschek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knut","family":"Kr\u00f6ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Kowall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans","family":"Santosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Stang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,19]]},"reference":[{"key":"2061_CR1","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","volume":"361","author":"SJ Connolly","year":"2009","unstructured":"Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L (2009) RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361:1139\u20131151","journal-title":"N Engl J Med"},{"key":"2061_CR2","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMoa1107039","volume":"365","author":"CB Granger","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, Wallentin L, ARISTOTLE Committees and Investigators (2011) Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365:981\u201392","journal-title":"N Engl J Med"},{"key":"2061_CR3","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","volume":"365","author":"MR Patel","year":"2011","unstructured":"Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM, ROCKET AF Investigators (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 365:883\u2013891","journal-title":"N Engl J Med"},{"key":"2061_CR4","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1160\/TH11-07-0517","volume":"106","author":"P Kirchhof","year":"2011","unstructured":"Kirchhof P, Lip GY, Van Gelder IC, Bax J, Hylek E, K\u00e4\u00e4b S, Schotten U, Wegscheider K, Boriani G, Ezekowitz M, Diener H, Heidbuchel H, Lane D, Mont L, Willems S, Dorian P, Vardas P, Breithardt G, Camm AJ (2011) Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options. Executive summary of the report from the 3rd AFNET\/EHRA consensus conference. Thromb Haemost 106:1012\u201319","journal-title":"Thromb Haemost"},{"key":"2061_CR5","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1093\/eurheartj\/ehq117","volume":"31","author":"GY Lip","year":"2010","unstructured":"Lip GY, Huber K, Andreotti F, Arnesen H, Airaksinen JK, Cuisset T, Kirchhof P, Mar\u00edn F, Consensus Document of European Society of Cardiology Working Group on Thrombosis (2010) Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and\/or undergoing coronary stenting: executive summary\u2013Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 31:1311\u20131318","journal-title":"Eur Heart J"},{"key":"2061_CR6","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1182\/blood-2014-04-571232","volume":"18","author":"N van Es","year":"2014","unstructured":"van Es N, Coppens M, Schulman S, Middeldorp S, B\u00fcller HR (2014 Sep) Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials. Blood 18:124:1968\u20131975","journal-title":"Blood"},{"key":"2061_CR7","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1055\/s-0038-1637750","volume":"44","author":"HY Lim","year":"2018","unstructured":"Lim HY, Nandurkar H, Ho P (2018) Direct oral anticoagulants and the paradigm shift in the management of venous thromboembolism. Semin Thromb Hemost 44:261\u2013266","journal-title":"Semin Thromb Hemost"},{"key":"2061_CR8","doi-asserted-by":"publisher","DOI":"10.3238\/zfa.2016.0028-0032","author":"K Weckbecker","year":"2016","unstructured":"Weckbecker K, Bleckwenn M, Dinkel K, M\u00fccke M (2016) Einsatz der Neuen oralen. Antikoagulanzien in Hausarztpraxen.https:\/\/doi.org\/10.3238\/zfa.2016.0028-0032","journal-title":"Antikoagulanzien in Hausarztpraxen"},{"key":"2061_CR9","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.thromres.2014.10.002","volume":"134","author":"R Provid\u00eancia","year":"2014","unstructured":"Provid\u00eancia R, Lerkevang Grove E, Husted S, Barra S, Boveda S, Morais J (2014) A meta-analysis of phase III randomized controlled trials with novel oral anticoagulants in atrial fibrillation: comparisons between direct thrombin inhibitors vs. factor Xa inhibitors and different dosing regimens. Thromb Res 134:1253\u20131264","journal-title":"Thromb Res"},{"key":"2061_CR10","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1182\/blood-2014-07-590323","volume":"124","author":"C Chai-Adisaksopha","year":"2014","unstructured":"Chai-Adisaksopha C, Crowther M, Isayama T et al (2014) The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis. Blood 124:2450\u20132458","journal-title":"Blood"},{"key":"2061_CR11","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1016\/j.jacc.2015.09.024","volume":"66","author":"MW Sherwood","year":"2015","unstructured":"Sherwood MW, Nessel CC, Hellkamp AS et al (2015) Gastrointestinal bleeding in patients with atrial fibrillation treated with rivaroxaban or warfarin: ROCKET AF Trial. J Am Coll Cardiol 66:2271\u20132281","journal-title":"J Am Coll Cardiol"},{"key":"2061_CR12","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1177\/1756283X17702092","volume":"10","author":"D Deutsch","year":"2017","unstructured":"Deutsch D, Bousti\u00e8re C, Ferrari E, Albaladejo P, Morange PE, Benamouzig R (2017) Direct oral anticoagulants and digestive bleeding: therapeutic management and preventive measures. Therap Adv Gastroenterol 10:495\u2013505","journal-title":"Therap Adv Gastroenterol"},{"key":"2061_CR13","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1253\/circj.CJ-16-0917","volume":"81","author":"HT Yu","year":"2017","unstructured":"Yu HT, Kim TH, Uhm JS, Kim JY, Pak HN, Lee MH, Joung B (2017) Clinical significance of hematuria in atrial fibrillation with oral anticoagulation therapy. Circ J 81:158\u2013164","journal-title":"Circ J"},{"key":"2061_CR14","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1160\/TH16-11-0874","volume":"117","author":"MP Brekelmans","year":"2017","unstructured":"Brekelmans MP, Scheres LJ, Bleker SM, Hutten BA, Timmermans A, B\u00fcller HR, Middeldorp S (2017) Abnormal vaginal bleeding in women with venous thromboembolism treated with apixaban or warfarin. Thromb Haemost 117:809\u2013815","journal-title":"Thromb Haemost"},{"key":"2061_CR15","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1111\/1471-0528.15388","volume":"125","author":"L Scheres","year":"2018","unstructured":"Scheres L, Brekelmans M, Ageno W, Ay C, B\u00fcller HR, Eichinger S, Hutten BA, Klok FA, Middeldorp S, Schreiber K, Stach K, Blondon M, Delluc A (2018) Abnormal vaginal bleeding in women of reproductive age treated with edoxaban or warfarin for venous thromboembolism: a post hoc analysis of the Hokusai-VTE study. BJOG 125:1581\u20131589","journal-title":"BJOG"},{"key":"2061_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.urology.2017.11.023","volume":"114","author":"NR Bhatt","year":"2018","unstructured":"Bhatt NR, Davis NF, Nolan WJ, Flynn RJ, McDermott T, Thomas AZ, Manecksha RP (2018) Incidence of visible hematuria among antithrombotic agents: a systematic review of over 175,000 Patients. Urology 114:27\u201332","journal-title":"Urology"},{"key":"2061_CR17","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.vph.2016.11.003","volume":"87","author":"AH Bryk","year":"2016","unstructured":"Bryk AH, Pir\u00f3g M, Plens K, Undas A (2016) Heavy menstrual bleeding in women treated with rivaroxaban and vitamin K antagonists and the risk of recurrent venous thromboembolism. Vascul Pharmacol 87:242\u2013247","journal-title":"Vascul Pharmacol"},{"key":"2061_CR18","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1053\/j.gastro.2013.09.041","volume":"145","author":"J Beyer-Westendorf","year":"2013","unstructured":"Beyer-Westendorf J, Pannach S (2013) Increase of gastrointestinal bleeding with new oral anticoagulants: problems of a meta-analysis. Gastroenterology 145:1162\u20131163","journal-title":"Gastroenterology"},{"key":"2061_CR19","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10654-010-9543-4","volume":"26","author":"A Stang","year":"2011","unstructured":"Stang A, Merrill RM, Ku\u00df O (2011) Nationwide rates of conversion from laparoscopic or vaginal hysterectomy to open abdominal hysterectomy in Germany. Eur J Epidemiol 26:125\u2013133","journal-title":"Eur J Epidemiol"},{"key":"2061_CR20","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s10654-013-9816-9","volume":"28","author":"A Stang","year":"2013","unstructured":"Stang A, K\u00e4\u00e4b-Sanyal V, Hense HW, Becker N, Kuss O (2013) Effect of mammography screening on surgical treatment for breast cancer: a nationwide analysis of hospitalization rates in Germany 2005\u20132009. Eur J Epidemiol 28:689\u2013696","journal-title":"Eur J Epidemiol"},{"key":"2061_CR21","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1001\/jama.2017.13890","volume":"318","author":"CJD Wallis","year":"2017","unstructured":"Wallis CJD, Juvet T, Lee Y, Matta R, Herschorn S, Kodama R, Kulkarni GS, Satkunasivam R, Geerts W, McLeod A, Narod SA (2017) Nam RK association between use of antithrombotic medication and hematuria-related complications. JAMA 318:1260\u20131271","journal-title":"JAMA"},{"key":"2061_CR22","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/pds.4580","volume":"28","author":"A Ruig\u00f3mez","year":"2019","unstructured":"Ruig\u00f3mez A, Brobert G, Suzart-Woischnik K, Garc\u00eda-Rodr\u00edguez LA (2019) Ascertainment and validation of major bleeding events in a primary care database. Pharmacoepidemiol Drug Saf 28:148\u2013155","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2061_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vph.2017.05.001","volume":"93","author":"R Godin","year":"2017","unstructured":"Godin R, Marcoux V, Tagalakis V (2017) Abnormal uterine bleeding in women receiving direct oral anticoagulants for the treatment of venous thromboembolism. Vascul Pharmacol 93:1\u20135","journal-title":"Vascul Pharmacol"},{"issue":"Suppl 1","key":"2061_CR24","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S0049-3848(17)30058-0","volume":"151","author":"F Moustafa","year":"2017","unstructured":"Moustafa F, Fern\u00e1ndez S, Fern\u00e1ndez-Capit\u00e1n C, Nieto JA, Pedrajas JM, Vison\u00e1 A, Valero B, Marchena PJ, Braester A, Monreal M (2017) RIETE Investigators. Uterine bleeding during anticoagulation in women with venous thromboembolism. Thromb Res 151(Suppl 1):S1\u2013S5","journal-title":"Thromb Res"},{"key":"2061_CR25","unstructured":"Guelker JA, Kr\u00f6ger K, Kowall B, Ilousis D, Santosa F, Stang A. Increasing use of anticoagulants in Germany and its impact on hospitalization for gastrointestinal bleeding. Thromb Res, in press"},{"key":"2061_CR26","doi-asserted-by":"publisher","first-page":"e465","DOI":"10.1016\/S2352-3026(17)30141-2","volume":"4","author":"GI Simon","year":"2017","unstructured":"Simon GI, Craswell A, Thom O, Fung YL (2017) Outcomes of restrictive versus liberal transfusion strategies in older adults from nine randomised controlled trials: a systematic review and meta-analysis. Lancet Haematol 4:e465\u2013e474","journal-title":"Lancet Haematol"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-020-02061-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-020-02061-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-020-02061-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T12:52:19Z","timestamp":1613739139000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-020-02061-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,19]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["2061"],"URL":"https:\/\/doi.org\/10.1007\/s11239-020-02061-3","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,19]]},"assertion":[{"value":"19 February 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}